Effect of Hormonal Replacement Therapy on Nocturia in Postmenopausal Women

Launched by UNIVERSITY HOSPITAL, GHENT · Jun 12, 2020

Keywords

ClinConnect Summary

This clinical trial is studying how different hormonal replacement therapies might help postmenopausal women who experience nocturia, which is the need to wake up at night to urinate. The study has two parts: the first part looks at how common nocturia is among postmenopausal women and what factors might contribute to it. The second part examines the effects of ten different hormonal treatments on this condition.

To participate in this study, women need to be in the early stages of menopause and experiencing symptoms like hot flashes. However, women currently taking hormonal replacement therapy or those with certain health issues, such as thyroid problems or a history of mental health disorders, cannot join. Participants will have the opportunity to contribute to important research that may improve treatment options for nocturia in postmenopausal women. This study is currently recruiting participants, so it’s a great chance to be involved in advancing women’s health.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • Women with postmenopausal symptoms (hot flushes, atrophy, ..)
• • All women were 'early' postmenopausal stages +1a,+1b or +1c as defined by the 'Stages of Reproductive Aging Workshop' (STRAW) criteria
• Exclusion Criteria:
• • Intake of HRT on the moment of inclusion
• • women with thyroid dysfunction
• • women using antihypertensive agents
• • women with a history of psychiatric or neurological disorders
• • women with a history of alcohol or drug addiction.